Neurocrine Biosciences In... (NBIX)
113.11
-0.89 (-0.78%)
At close: Mar 28, 2025, 3:59 PM
110.80
-2.04%
Pre-market: Mar 31, 2025, 06:07 AM EDT
Neurocrine Biosciences Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Net Income | 341.3M | 249.7M | 154.5M | 89.6M | 407.3M | 37.01M | 21.11M | -142.54M | -141.09M | -88.93M | -60.54M | -46.09M | 5.03M | 37.57M | -7.97M | -51.04M | -88.61M | -207.3M | -107.2M | -22.19M | -45.77M | -30.26M | -94.54M | -36.91M | -28.81M | -16.8M | -20M | 5.1M | 5.9M |
| Depreciation & Amortization | -2.7M | 21.3M | 15.6M | 10.9M | 8.6M | 7.45M | 4.02M | 2.4M | 1.45M | 1.01M | 827K | 671K | 657K | 694K | 1.44M | 3.18M | 7.61M | 9.4M | 10.57M | 10.09M | 7.08M | 3.69M | 3.1M | 2.65M | 2.2M | 2.1M | 1.7M | 1.3M | 1M |
| Stock-Based Compensation | 195.5M | 194.3M | 173.1M | 134.2M | 100M | 75.26M | 58.07M | 42.52M | 28.46M | 28.39M | 10.38M | 6.82M | 5.48M | 2.92M | 3.13M | 5.54M | 7.99M | 9.98M | 14.37M | 533K | 533K | 1.69M | 1.18M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | n/a | 47.8M | -17.2M | -9.2M | -23.6M | 21.88M | 8.7M | -3.99M | -300K | -610K | -418K | -1.43M | -263K | -7.33M | -4.89M | -15.63M | -1.76M | -478K | -519K | 245.62M | 254.23M | 361.8M | 215.62M | 1.85M | 433K | 2.2M | -2.3M | 1.8M | -700K |
| Other Non-Cash Items | 184.4M | -46.9M | 44.5M | 800K | 61.2M | 21.07M | 19.23M | 12.44M | -878K | 10.13M | 14K | -2.78M | -32.84M | -36.51M | 65.97M | -2.35M | 6.74M | 121.81M | 7.88M | -21.99M | -36.36M | 81K | -1.43M | 10.56M | 7.53M | 2.2M | 9.9M | 2.8M | 500K |
| Deferred Income Tax | -123.1M | -56.7M | 19.1M | 4.3M | -310.7M | 11.02M | 689K | -348K | 89K | 2.7M | 570K | -327K | 61K | -837K | -3.46M | 4.75M | 4.24M | -10.11M | -13.89M | -533K | -533K | 44.94M | -1.18M | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | 28.2M | -67.4M | 16.7M | -37.9M | 241K | -1.76M | -8.81M | 5.78M | 8.7M | 1.61M | 12.1M | -13.67M | -4.52M | -9.16M | -13.18M | -12.14M | 16.88M | -11.05M | 3.3M | -24.93M | 16.98M | 13.51M | 1.85M | 433K | 2.2M | -2.3M | 1.8M | -700K |
| Operating Cash Flow | 595.4M | 389.9M | 339.4M | 256.5M | 228.5M | 152.05M | 101.36M | -94.33M | -106.18M | -38M | -47.14M | -29.61M | -35.29M | -681K | 49.94M | -53.09M | -74.17M | -59.33M | -99.33M | -30.79M | -99.99M | 37.13M | -79.36M | -21.86M | -18.64M | -10.3M | -10.7M | 11M | 6.7M |
| Capital Expenditures | -38.2M | -28.3M | -16.5M | -23.4M | -10.9M | -14.75M | -24.81M | -6.94M | -4.11M | -1.93M | -1.61M | -545K | -971K | -750K | -315K | -35K | -1.32M | -624K | -3.11M | -7.24M | -53.15M | -50.44M | -5.3M | -3.81M | -2.44M | -2.1M | -3.8M | -6.4M | -1.6M |
| Acquisitions | n/a | n/a | -42.7M | 4.6M | 0.00 | 8K | 34K | 7K | 13K | 9K | 45K | 40K | 32K | 245K | 336K | 1.19M | 603K | 129K | n/a | n/a | n/a | 36.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.06B | -1.41B | -628.9M | -804.7M | -735.5M | -797.17M | -545.96M | -583.41M | -298.78M | -449.05M | -257.54M | -145.33M | -166.31M | -139.1M | -89.79M | -16.8M | -36.99M | -94.64M | -64.04M | -382.83M | -593.72M | -448.29M | -401.59M | -175.89M | -151.58M | -87.7M | -41.6M | -113.1M | -85.2M |
| Sales Maturities Of Investments | 967.5M | 972.4M | 511M | 697.9M | 750.5M | 669.69M | 327.82M | 339.09M | 415.83M | 255.12M | 154.13M | 151.28M | 132.52M | 134.26M | 34.84M | 27.61M | 82.13M | 117.13M | 186.91M | 399.97M | 645.05M | 300.49M | 360.87M | 163.05M | 78.35M | 68.6M | 50M | 112.3M | 38.9M |
| Other Investing Acitivies | -0.00 | n/a | -117.9M | -4.6M | 15M | -68.86M | 34K | 383K | -92K | 40K | -388K | -108K | -29K | 1.8M | 223K | 84K | 1K | -1.16M | 525K | -525K | 20.29M | -25.04M | n/a | n/a | n/a | n/a | 100K | n/a | -700K |
| Investing Cash Flow | -126.8M | -467.1M | -177.1M | -130.2M | 4.1M | -211.07M | -242.91M | -250.87M | 112.86M | -195.81M | -105.37M | 5.34M | -34.76M | -3.55M | -54.7M | 12.06M | 44.43M | 20.84M | 120.28M | 9.38M | 18.47M | -186.65M | -46.02M | -16.64M | -75.67M | -21.2M | 4.7M | -7.2M | -48.6M |
| Debt Repayment | -308.8M | n/a | -279M | -100K | -186.9M | n/a | n/a | 502.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.49M | 56.59M | -5.76M | -6.64M | 29.69M | 14.45M | 2.25M | 1.82M | 757K | n/a | 1.5M | -100K | -700K |
| Common Stock Repurchased | -300M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 122.1M | 65.3M | n/a | 27.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 236K | n/a | 104K | n/a | 15K | n/a | n/a | 100K | n/a |
| Financial Cash Flow | -486.7M | 65.3M | -234.3M | 27.4M | -157.8M | 27.31M | 29.53M | 516.65M | 2.39M | 276.99M | 138.73M | 5.3M | 83.7M | 286K | 21.48M | 9.9M | -1.45M | 57.18M | 10.09M | 10.33M | 36.69M | 211.06M | 5.81M | 181.3M | 94.13M | 41M | 1.9M | 700K | 46.8M |
| Net Cash Flow | -18.1M | -11.6M | -73.3M | 153.7M | 74.8M | -31.71M | -112.02M | 171.44M | 9.07M | 43.18M | -13.78M | -18.96M | 13.65M | -3.94M | 16.72M | -31.14M | -31.2M | 18.68M | 31.03M | -11.08M | -44.83M | 61.54M | -119.58M | 142.81M | -187K | 9.6M | -4.1M | 4.5M | 4.9M |
| Free Cash Flow | 557.2M | 361.6M | 322.9M | 233.1M | 217.6M | 137.31M | 76.55M | -101.27M | -110.29M | -39.93M | -48.75M | -30.15M | -36.27M | -1.43M | 49.63M | -53.13M | -75.5M | -59.96M | -102.44M | -38.03M | -153.13M | -13.31M | -84.67M | -25.66M | -21.09M | -12.4M | -14.5M | 4.6M | 5.1M |